1887

Abstract

Ten strains of were tested by a cross-streaking method for in-vitro inhibition of 10 strains of fungi known to infect man; these were and . Significant inhibition of fungal growth was observed with all 10 strains of , but not with NCTC 10418, NCTC 6571 and NCTC 11931.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-45-5-380
1996-11-01
2022-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/45/5/medmicro-45-5-380.html?itemId=/content/journal/jmm/10.1099/00222615-45-5-380&mimeType=html&fmt=ahah

References

  1. Spencer R. C. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30: Suppl 453–164
    [Google Scholar]
  2. Gardner P., Griffin W. B., Swartz M. N., Kunz L. J. Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med 1970; 48:735–749
    [Google Scholar]
  3. Kerr J. R. Suppression of fungal growth exhibited by Pseudomonas aeruginosa. J Clin Microbiol 1994; 32:525–527
    [Google Scholar]
  4. Kerr J. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J Infect 1994; 28:305–310
    [Google Scholar]
  5. Gillies R. R., Govan J. R. W. Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol 1966; 91:339–345
    [Google Scholar]
  6. Caticha O., Grover S., Winge D., Odell W. D. Stimulation of Candida albicans transition by human chorionic gonadotropin and a bacterial protein. Endocr Res 1992; 18:133–143
    [Google Scholar]
  7. Elander R. P., Mabe J. A., Hamill R. H., Gorman M. Metabolism of tryptophans by Pseudomonas aureofaciens. VI. Production of pyrrolnitrin by selected Pseudomonas species. Appl Microbiol 1968; 16:753–758
    [Google Scholar]
  8. Zhou P., Mocek U., Siesel B., Floss H. G. Biosynthesis of pyrrolnitrin. Incorporation of 13C, 15N double labelled D- and L-tryptophan. J Basic Microbiol 1992; 32:209–214
    [Google Scholar]
  9. Arima K., Imanaka M., Kousaka M., Fukuta A., Tamura G. Pyrrolnitrin, a new antibiotic substance produced by Pseudomonas. Agr Biol Chem 1964; 28:575–576
    [Google Scholar]
  10. Cohen R., Roth F. J., Delgado E., Ahearn D. G., Kaiser M. H. Fungal flora of the normal human small and large intestine. N Engl J Med 1969; 280:638–641
    [Google Scholar]
  11. Govan J. R. W. Pseudomonas. In Collee J. G., Duguid J. P., Fraser A. G., Marmion B. P. Practical medical microbiology Edinburgh: Churchill Livingstone; 1989491–504
    [Google Scholar]
  12. Govan J. R. W., Nelson J. W. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992; 48:912–930
    [Google Scholar]
  13. Gordee R. S., Matthews T. R. Evaluation of the in vitro and in vivo antifungal activity of pyrrolnitrin. Antimicrob Agents Chemother 1967; 7:378–387
    [Google Scholar]
  14. Valsecchi R., Foiadelli L., Cainelli T. Contact dermatitis from pyrrolnitrin. Contact Dermatitis 1981; 7:340
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-45-5-380
Loading
/content/journal/jmm/10.1099/00222615-45-5-380
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error